- Open Access
A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trial
International Journal of Behavioral Nutrition and Physical Activity volume 18, Article number: 34 (2021)
It is estimated that around 30% of breast cancers in post-menopausal women are related to lifestyle. The breast cancer-pooling project demonstrated that sustained weight loss of 2 to 4.5 kg is associated with an 18% lower risk of breast cancer, highlighting the importance of small changes in body weight. Our study aimed to assess the effectiveness a volunteer-delivered, community based, weight management programme (ActWELL) for women with a BMI > 25 kg/m2 attending NHS Scotland Breast Screening clinics.
A multicentre, 1:1 parallel group, randomised controlled trial was undertaken in 560 women aged 50 to 70 years with BMI > 25 kg/m2. On completion of baseline measures, all participants received a breast cancer prevention leaflet. Intervention group participants received the ActWELL intervention which focussed on personalised diet advice and pedometer walking plans. The programme was delivered in leisure centres by (the charity) Breast Cancer Now volunteer coaches.
Primary outcomes were changes between groups at 12 months in body weight (kg) and physical activity (accelerometer measured step count).
Two hundred seventy-nine women were allocated to the intervention group and 281 to the comparison group. Twelve-month data were available from 240 (81%) intervention and 227 (85%) comparison group participants. Coaches delivered 523 coaching sessions and 1915 support calls to 279 intervention participants. Mean weight change was − 2.5 kg (95% CI − 3.1 to − 1.9) in the intervention group and − 1.2 kg (− 1.8 to 0.6) in the comparison group. The adjusted mean difference was − 1.3 kg (95% CI − 2.2 to − 0.4, P = 0.003). The odds ratio for losing 5% weight was 2.20 (95% CI 1.4 to 3.4, p = 0.0005) in favour of the intervention. The adjusted mean difference in step counts between groups was 483 steps/day (95% CI − 635 to 1602) (NS).
A community weight management intervention initiated at breast screening clinics and delivered by volunteer coaches doubled the likelihood of clinically significant weight loss at 12 months (compared with usual care) offering significant potential to decrease breast cancer risk.
Database of registration: ISCRTN.
Date trial registered:21.07.2017.
Date of enrolment of first participant: 01.09.2017.
Breast cancer is the most common cancer in women worldwide. In Scotland, the disease accounts for 29% of all cancers diagnosed . Incidence is increasing and current predictions from ISD (Scottish Government) suggest a rise of 27.5% between 2008 and 2012 and 2023–2027 .
Whilst many factors are implicated in the aetiology, current estimates suggest that around 30% of breast cancers in post-menopausal women are related to physical inactivity, alcohol consumption and body fatness . Gaining weight in adult life is also a strong predictor of breast cancer (especially in women who have not taken hormone replacement therapy) . The incidence of breast cancer differs from other obesity related cancers in that rates are 14% lower for women living in the most deprived areas compared with the least deprived .
Observational data has consistently shown that relatively modest weight losses in post-menopausal women are associated with significant risk reduction in breast cancer [4, 6, 7]. A report from the breast cancer-pooling project demonstrated that modest, sustained intentional weight loss (over 10 years) of 2 to 4.5 kg is associated with an 18% lower risk of the disease . This magnitude of change is similar to the 3% body weight loss noted by NICE as associated with reductions in obesity related co-morbidities .
Women meeting at least five of the World Cancer Research Fund prevention guidelines for lifestyle (including physical activity and alcohol) show a 60% lower risk for breast cancer compared to women meeting none of the guidelines . A recent systematic review reported that high versus low adherence to cancer prevention guidelines was associated with consistent reductions in breast cancer incidence . Whilst awareness about obesity related behaviours and other lifestyle habits and cancer risk is increasing  there are few interventions (policy or individual level) directed towards supporting weight management and other modifiable breast cancers risk factors in women approaching or after menopause .
Most (71%) Scottish women aged 50 to 70 years accept invitations to attend NHS Scotland Breast Screening Programme (NHSSBSP) every 3 years and as such the service provides a unique opportunity to endorse and support lifestyle interventions for large numbers of women . The cancer research “gap analysis” reviews by Breast Cancer Campaign [4, 15] highlighted the role of breast screening programmes as an opportunistic “teachable moment” for promoting cancer prevention activities.
Actions at policy level potentially offer equitable approaches to assist the population to achieve desirable changes in weight-related behaviours but in the UK these are limited and principally focussed on childhood obesity. In Scotland, the breast cancer community is currently exploring innovative and sustainable preventative opportunities to support weight management programmes for breast cancer risk reduction utilising existing community asset approaches including volunteers, physical resources such as leisure centres and existing NHS screening services.
We aimed to evaluate the impact of a novel community based, weight management programme (ActWELL) in women with a body mass index (BMI) > 25 kg/m2 attending routine NHS breast screening clinics.
The study design was a multicentre, 1:1 parallel group, randomised controlled trial conducted in four NHSSBSP screening centres in Scotland from August 2017 to September 2019. The full protocol is reported elsewhere . See also CONSORT checklist.
Using the data from women with excess body weight (BMI > 25 kg/m2) in the ActWELL feasibility study  (mean body weight 80.9 ± 17.9 kg), a total of 414 women (207 per group) were required to detect a 7% weight between groups change at 90% power (alpha 0.05). Allowing for at a 25% drop out (based on our findings from the feasibility study) we sought to randomise a sample size of 552. The feasibility study randomised 10 women per site per month and we estimated that it would take up to 14 months for four sites to attain the sample size in this trial (allowing for holidays).
Based on the ‘Walking for Wellbeing in the West’ study  we estimated that to detect a difference of 2000 steps between groups at follow-up, at 90% power, 102 women (51 per group) would be required to provide data at both time points. Allowing for 20% drop out (plus any equipment malfunction/postal losses) we aimed to recruit a further 30% bringing the total enrolment to 146 of the 552 participants for this aspect of the study.
Our sample size was based on numbers of women needed to provide meaningful data on both primary outcomes recognising that much smaller numbers were needed for assessing changes in physical activity.
Participants and recruitment
We requested that all attendees at routine NHS breast screening appointments were informed about the study by (NHSSBSP) staff via a leaflet (given by clinic reception staff at check in) and a brief 30-s introductory conversation verbally after mammographic procedures were completed. Interested clients were asked to complete an invitation card and leave it in a dedicated box at the appointment venue. Respondents were then contacted by research nurses to assess BMI and other eligibility criteria.
Attending, or invited to attend, routine breast screening clinics (not recall clinics)
Measured BMI > 25 kg/m2
Age 50 to 70 years
Currently undergoing treatment for any malignant condition (excluding basal or squamous cell skin cancers)
Reported contra-indication to physical activity (e.g. recent surgery)
Reported contra-indication to weight loss (e.g. currently following a recovery programme for weight gain)
On a specialised medical diet e.g. gluten free
Diagnosis of Type 1 diabetes
Current use of insulin
No telephone contact
Unable to consent
Respondents were contacted by telephone on a “first come, first served” basis until all the available research nurse appointments for the week were filled. Women who were not contacted about the study were sent information on reducing breast cancer risk as were women who were contacted but found to be ineligible for the study. No cards were held for future contact. The number of appointments (e.g. staff time made available) was based on the results of the feasibility study where 10 participants per week per clinic were successfully recruited. Participants who are considered eligible were invited to attend their local research centre to provide informed consent before commencing baseline measures.
During preparation for recruitment, senior screening management staff reported that they a) were reluctant or unable to provide data on number of attendances, and the numbers of cards given out, b) staff who did not feel comfortable introducing the concept of lifestyle would not be compelled to do so, c) verbal information on the study would only be provided if time permitted (and may be difficult in busy clinics), d) communications on mobile screening units were considered difficult at some sites because no reception staff were available. It also became apparent that the demographic backgrounds of screening attendees were dependent on which general practice areas were being invited for screening and where mobile screening vans were sent.
Procedures are outlined here and full details are provided elsewhere . A full list of measured outcomes is presented in Table 1. Research nurses at each site collected data at baseline, 12 weeks (by telephone) and 12 months. At baseline, demographic data were collected.
The two primary outcomes were measured change in body weight and change in step count (physical activity) by 12 months. Both were measured as the mean difference between groups at 12 months adjusted for baseline weight, site, minimisation variables, Scottish Index of Multiple Deprivation (SIMD) , ethnicity, home ownership and number of coach sessions. Physical activity was objectively measured using thigh worn activPAL™ (PAL Technologies Ltd., Glasgow, UK) accelerometers. A minimum of 4 days from a participant were required for the activPAL™ data to be considered valid .
Secondary outcomes were measured changes in waist circumference, self-reported moderate/vigorous minutes of physical activity (work, leisure, housework), sedentary behaviour (sitting time), eating habits, alcohol intake, psychosocial variables, HbA1C, CVD risk factors (non-fasting lipids) and non-fasting insulin, blood pressure, quality of life and health economic outcomes. Details of measurement tools are presented elsewhere .
Delivery and Process Outcomes: The lifestyle coaches kept records on intervention delivery and after 5 completed participant sessions reported adherence to key delivery components (scaled as never to always). In addition, audio-recorded coach sessions were assessed for adherence to protocol.
Perceptions, experiences and perceived acceptability of the intervention were attained through qualitative semi-structured interviews. These were conducted with one member of NHSSBSP staff at each site (who had volunteered as an ActWELL champion), volunteer coaches (by site), leisure centre staff (one from each site) and intervention and comparison group participants (selected by site and socio-economic area of residence). All interviews were audio-recorded, transcribed and coded for thematic analysis.
In addition, intervention participants were invited to return exit questionnaires on perceived value of specific components of the intervention programme, acceptability and recommendations to others.
Following the baseline visit, eligible women who had consented to participate were randomised centrally at a 1 to 1 ratio to receive either the ActWELL programme or usual care (comparison group) using the web-based TRuST system developed and managed by the Tayside Clinical Trials Unit. Randomisation was stratified by site and minimised by socio-economic status based on Social index of Multiple Deprivation (SIMD). In addition, 146 women (73 from each group) were randomly allocated by the TRuST system to receive the activPAL™ monitor (accelerometer) (see ‘Sample size’ above). This second randomisation was done at the baseline visit so that the research nurse could provide and fit the activPAL™ monitor to those allocated to receive it. Participants, coaches, trial manager and administrator were aware of intervention group allocation, but research nurses (who collected data) and the trial statistician were not. It should be noted that both primary outcomes used objective measurement approaches.
The intervention was based on the COM-B model of behaviour change . This incorporated increased capability for lifestyle change (via a volunteer coach delivered personalised programme), enhanced opportunities for greater physical activity (via pedometer-based programmes and introduction to local leisure centres) and increased motivation for weight management e.g. by raising awareness of breast cancer risk reduction within screening.
The programme was delivered in two individual, one to one sessions (60 min and 45 min) in the first 12 weeks of the intervention period and 9 (15-min) support calls over the following 9 months, totalling 4 h contact over a 12-month period. The programme was delivered by volunteer coaches who were recruited and managed by the charity Breast Cancer Now. The charity recruited volunteers who had relevant experience with assisting people undertake life changes (e.g. nurses, teachers, church work) and they underwent a 2 day bespoke training programme from the experts in the research team (including physical activity and dietetics). Coaches were then asked to undertake 2 full coaching sessions (with feedback) from participant volunteers. On going support (e.g. frequently asked questions, local WhatsApp group for coaches and questions and queries were handled by the Breast Cancer Now project officer on an on-going basis.
Face-to-face visits between volunteer coach and participants took place in non-gym space (e.g. an office) in local leisure centres. The main physical activity component of the intervention was a pedometer-based walking programme, introduced at the first face-to-face visit with a 10-min “walk and talk” session. Participants were supported to increase physical activity towards accumulating at least 150 min of moderate intensity physical activity per week through the provision of graduated walking goals and then, where appropriate, towards 300 min per week (Based on Scottish Intercollegiate Guidelines Network (SIGN)  guidance on weight management).
All intervention participants were set a target goal of a 7% reduction in body weight and provided with a personalised energy prescription of 2508 kJ (600 kcal) below that required for weight maintenance. Bodyweight scales were offered in order to undertake self-monitoring. If the weight loss target was attained then guidance was given on weight loss maintenance. Behavioural change techniques (BCTs) included education, motivational interviewing, goal setting, action and coping planning implementation intentions, self-monitoring of body weight and steps and feedback. The content and design of the programme was based on the feasibility study findings, views of the target group and those involved in facilitating the programme. At the end of the study we also offered referrals to NHS weight loss services to women who still had a BMI > 25 kg/m2 as well as information on other weight management programmes (including internet based programmes). Full details of programme optimisation are described elsewhere . The details of the programme content are outlined in Table 2.
All participants (including all the comparison group participants) underwent all data collection procedures at baseline, 12 weeks and 12 months including weighing. On completion of baseline measures all participants received a breast cancer prevention leaflet  (which noted the relevance of lifestyle factors). On completion of their 12 months follow up visit women in the comparison group were offered a single personalised coaching session from volunteers and the ActWELL intervention written pack.
Primary and secondary outcomes
Full details of analytical procedures are described elsewhere and based on a pre-datalock Statistical Analysis Plan (SAP) . In summary, the primary analysis used an intention to treat analysis with all available data using mixed models. We carried out multiple linear regression analyses with mixed effects models adjusted for the corresponding baseline values with group allocation, minimisation variables SIMD, site, ethnicity, home ownership and number of coach sessions as fixed effects. Sensitivity analysis utilised measures of Akaike’s Information Criterion (AIC) to estimate the fit of models. Transformations were used for secondary outcomes where normality was not plausible. SAS software (version 9.4, SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses.
The within-trial health economics analysis adopted the perspective of the UK NHS and compared the health care costs and health-related quality of life effects (measured by the ED-5D-5L instrument, summarised by changes in Quality Adjusted Life Years, “QALYs”) for both groups over 12 months after randomisation. Costs are reported in 2017/18 pounds sterling (£), using NHS reference cost 2017/18 and the Unit Costs of Health & Social Care 2018 to value the resource use [31, 32] with adjustments made for inflation using the Hospital & Community Health Services (HCHS) Index and the new Health Services Index using CPI (Health).
Self-reported health care resource use measurement included costs in primary care (general practitioner, district nurse, practice nurse and other community health professional visits) and secondary care (emergency, hospital admissions and hospital outpatient attendances). ActWELL intervention costs comprised the Breast Cancer Now Co-ordinator salary, (adjusted to reflect only time spent on intervention delivery activities, such as recruiting and co-ordinating volunteers), management cost of Breast Cancer Now, training time and associated expenditure, consumables (training packs and participant materials) and travel costs for volunteer coaches to reach training centres, update visits and leisure centres.
Patient and public involvement
The intervention development (invitation design and wording, content, pitch, interactive materials, use of behaviour change techniques) at feasibility stage and the definitive trial were informed by focus group discussions with women aged 50 to 70 years who had previously received an invitation to attend breast screening. In addition, feedback from participants of the feasibility trial had a direct influence on delivery design (timing, content) for the RCT.
Recruitment and follow-up
Interest in participating in the ActWELL programme was high, with 3769 women requesting project information over a 12-month period, and recruitment closed ahead of schedule. A total of 1711 respondents were contacted by research nurses for further details. Of these, 507 (28%) were known to have a BMI < 25 kg/m2 and therefore ineligible for study inclusion. No information on physical activity was collected at this stage. Around one third (n = 563) declined to participate after discussing study requirements and did so without giving reasons [Flow Diagram A].
In total, 560 women were randomised (279 to intervention, 281 to comparison). At 12 weeks, 527 (93% intervention, 95% comparison) remained in the study, and at 12 months, 465 (81% intervention, 85% comparison) returned for follow up measures of the primary outcome of body weight [Flow Diagram A]. In accordance with study size requirements, 144 participants were randomised (72 intervention and 72 comparison) to the activPAL™ accelerometer (second primary outcome) and 125 (93% intervention, 95% comparison) provided at least 4 days of data recording (mean 6.8 days SD 0.74). At 12 months, 89 provided useable data (63% intervention, 67% comparison) [Flow Diagram B] and 82 people provided useable data at both time points. Device issues and failure to return the activPAL™ units were the major causes for the low number of usable datasets.
Participants came from all socioeconomic groups; 16% were from SIMD 1 and 2 (highest areas of social deprivation). The mean age at baseline was 59.1 years (SD 5.44) and the majority were well educated and in paid employment (Table 3). Most participants (63.2%) reported being post-menopausal with a further 8.2% as peri-menopausal. Almost half (48.8%) of the randomised participants had a body mass index in the obese category (> 30 kg/m2).
Outcomes- body weight change
The mean (measured) weight loss at 12 months in the intervention group was 2.5 kg (95% confidence interval (CI) = loss of between 1.9 kg and 3.1 kg) and the weight loss in the comparison group was 1.2 kg (95% CI = loss of between 0.6 kg and 1.8 kg). The primary analysis of weight loss at 12 months adjusted for baseline, site, SIMD and other SAP variables showed a loss of 1.3 kg in favour of the intervention (95% CI = loss of between 0.4 kg and 2.2 kg; P = 0.003). Differences in the self-reported body weight between baseline and 12 months also show a significantly greater weight loss in favour of the intervention group after adjustment for all SAP variables (weight loss of 1.2 kg; 95% CI = loss of between 0.3 kg and 2.2 kg; p = 0.014). It is notable that self-reported weight continued to decline between 12 weeks and 12 months when the intervention contact was telephone based (Table 4).
The mean percentage weight loss (using measured body weight) at 12 months in the intervention group was − 3.07% (95% CI = loss of between 3.77 to 2.37%) compared with − 1.34% (SD 5.76) (95%CI loss of between − 2.07% to − 0.60%) in the comparison group. A greater proportion of intervention participants compared to comparison group attained 5% weight loss. In addition, 51% achieved greater than 2 kg weight loss (the minimum associated with breast cancer risk reduction) (8) in the intervention group compared to 27% in comparison group. It is notable that 19% of women in the intervention group achieved 7% weight loss and were given advice on weight loss maintenance, which constrained the potential of total weight loss in this group.
The mean difference in waist circumference and BMI reductions were significantly greater in the intervention group (Table 4).
Outcomes – physical activity change
The mean daily step count at 12 months was lower in both groups than it was at baseline. For those providing valid data (minimum of 4 days of data), in the intervention group the reduction was 69 steps (95% CI − 952 to 1091) and a reduction of 435 steps (95% CI − 1074 to 205) in the comparison group. The primary outcome analysis of adjusted mean difference between groups at 12 months was an additional 483 steps, but this difference was not statistical significant from baseline (Table 5).
The secondary outcome of self-reported physical activity indicated that both groups increased activity over the study period with a moderately higher amount reported in the intervention group (mean difference ns). There was no difference in sedentary behaviour between groups. Following standard practice with self-reported physical activity we capped the maximum daily activity data at 360 mins/day  and when this was applied there was a significantly greater increase in activity in favour of the intervention group (Table 6).
Health Behaviours and psychosocial variables
No significant differences between groups were detected in alcohol or fruit and vegetable intake (Table 7). It is notable that reported changes in attempts to alter physical activity and alcohol over the study period indicated a significantly greater odds of positive changes in the intervention group (Table 8). No significant differences were found for any of the psychosocial variables or EQ-5D quality of life domains (Table 9).
Cardiovascular and diabetes risk
No significant differences between groups were detected although both measures of insulin and total cholesterol indicate a favourable direction of change (Table 10).
No adverse events reported by participants were related to participation in the trial (Table 11).
Health economic analysis
Intervention costs are presented in Table 12. Table 13 indicates that the health care costs were significantly higher in the intervention group relative to the comparison group. There was a non-significant gain in EQ-5D in the intervention group relative to the comparison group. The incremental cost per QALY gained values ranged from £55,255 to £99,804 per QALY gained. Figure 1 indicates that the probability of the intervention being judged as cost-effective is below 20% (using the conventional threshold of cost-effectiveness as cost per QALY gain of up to £30,000 or less).
Intervention invitation, delivery, acceptability and responses
The invitation to participate in the intervention was dependent on the introduction and endorsement by NHSSBS screening staff. Interviews with the four ActWELL mammography champions indicated that there had been some concerns prior to the start of recruitment: that there may not be time during the tight clinic schedule to answer questions raised by women about the study; that women might be upset by the mention of lifestyle issues, including weight, during the screening process; that mentioning the study during screening might impact negatively on women’s willingness to attend for screening in future. However, no mammographers reported any instances of women feeling distressed about raising the issue of lifestyle. The mammographers described how the ActWELL introduction process generally became embedded into practice, sometimes with modifications, although these were generally minor in nature. No mammographers felt that including the ActWELL introduction in the screening process had impacted negatively on women’s willingness to attend for screening (Table 14).
Post study interviews with 24 ActWELL intervention and eight comparison participants indicated that the mammography setting was felt to have been an appropriate recruitment channel (Table 15). It is notable in the 12 months follow up exit questionnaires that 90.4% of 167 intervention participants who completed follow up measures reported they would still have been interested in the opportunity for a lifestyle intervention if this had not been a research study.
Post study interviews with eight coaches (Table 16) indicated that the intervention organisation process was well managed and straightforward. Overall, coaches felt a high level of confidence in carrying out their role, although some indicated nervousness and uncertainty in the initial stages and benefited from opportunities to practise and gain experience. Coaches noted a generally good level of engagement among ActWELL participants, with most starting off very enthusiastic. Over time, coaches found that engagement amongst participants varied, particularly after the face-to-face appointments ended and the intervention moved on to telephone support. One coach commented that most of their participants reported having lost a lot of weight before they had started on ActWELL, which may have impacted on further weight loss during the intervention.
Most (90%) participants attended both face-to-face consultations (mean visits 1.9 SD 0.28) and 59% completed the 9 planned telephone calls (mean 7.1 SD 2.81). Self-reported fidelity data was provided by 32 coaches who described “always” delivering key intervention components (n = 7) (range 67 to 96%). Independent fidelity analysis of recordings of 35 coaching sessions and 22 support calls found 69–88% adherence to protocol.
Data from the study exit questionnaires (n = 167) showed that most (91%) intervention participants said they found the face-to face contact very (73%) or quite (18%) helpful. Telephone contact was also rated highly with most participants reporting that they found it very (61%) or quite (23%) helpful. Overall, participants rated the programme well and 90% said they were very (63%) or quite (27%) likely to recommend it to others.
Post study interviews (n = 24) with intervention participants [Flow Diagram B] indicated that coaches were generally highly regarded. Four main areas were highlighted: the coach’s personality or manner, ability to empathise, the support provided throughout the programme, and their ability to understand how to motivate change. Other intervention aspects which were highlighted related to behavioural change techniques utilised (goal setting, telephone support, self-monitoring of step counts). [Flow Diagram B].
In terms of changes in lifestyle, interviewees tended to report a number of small rather than major changes to their diet. Participants spoke of increasing their fruit and vegetable intake, replacing foods and drinks, and greater portion control. There was some evidence from the interviews that participants had high levels of activity prior to ActWELL. However, one participant said that she felt her baseline number of steps was artificially high as she had increased her activity prior to meeting the lifestyle coach.
The results indicate that breast screening provides a promising and acceptable opportunity to initiate a weight management intervention programme. The delivery of the programme by volunteer coaches in leisure centres was achieved to a high degree of fidelity and resulted in clinically relevant weight loss, doubling the likelihood of achieving weight loss (5%) at 12 months with potential to decrease breast cancer risk. The weight loss is relatively modest but in line with that achieved by Ayeyard et al  (1·43 kg (95% CI 0·89–1·97) where weight loss was initiated in a primary care setting with the potential for significant impact at a population wide level if scaled up accordingly.
The programme design used an innovative approach for the engagement and delivery of a weight management programme, which has the potential to be rolled out across screening communities. This study adds trained volunteers to the groups (including veterans  and peer workers [36, 37]) who have been shown to successfully enhance existing efforts in obesity control. The demand and uptake of the programme was higher than anticipated and considerably higher than the number returned in the feasibility study. Qualitative data support the use of the screening setting as a “teachable moment”  and a trigger for considering health behaviours. Recent data from an Australian study  reported that 76.4% of 204,429 women agreed to have their height and weight measured at routine screening clinics, supporting the potential for initiating weight management advice/referrals.
The current programme provided an opportunity to engage with women from a wide range of sociodemographic backgrounds. The uptake across SIMD groups reflected the incidence distribution of breast cancer, the areas where the breast-screening programme was inviting women for mammography during the trial period, and interest in the programme. However, the uptake by women living in the most deprived areas was lower than that attained in the feasibility work, and ways to improve engagement deserve further exploration.
The response to the programme indicates that the approach taken was acceptable to women in the overweight and obese categories. The weight change detected was most likely due to small decreases in caloric intake by changes in a number of habitual behaviours (including portion sizes) rather than any one category of foods (e.g. sweet snacks, alcohol). Overall, the objective and subjective measures of physical activity suggest that participants were a very active group , although activity levels can often be inflated during periods of measurement and it is notable that all had excess body weight (which can make it harder to exercise). Responses to the query at baseline on whether participants had increased their physical activity (no time period indicated, but likely to include the time between recruitment and research nurse visit) show that 90% of participants said they had attempted to increase physical activity. These results suggest that the eligibility process could usefully have included a physical activity assessment. The impact of the intervention on physical activity is unclear because although the required number of participants received the accelerometers, too few were able to provide useable data.
The ActWELL intervention costs around £500 per participant (Table 13), which is comparable to a community-based weight management program run through the Scottish colorectal screening service (£546)  but more expensive than the only other widescale community based weight RCT reported in Scotland run through Scottish football clubs (£165)  or international football clubs (approx. £250) . In terms of cost-effectiveness, the health economics analysis results indicate that the gains in health-related quality of life over 12 months are not sufficiently large enough to conclude that the intervention is likely to be judged as cost-effective. However, the impact of the intervention on long term health gain (i.e. reduction in breast cancer risk) cannot be assessed in this 12 month assessment. Itis possible that adopting a longer time perspective, by extrapolating the changes in weight observed within the study over a future period, would produce more favourable results . Long-term modelling data  suggest that an intervention costing £500 used by overweight women aged 50–59 that led to a BMI reduction of 0.6 (comparable to ActWELL), with no regain of the weight lost, would have an incremental cost per QALY gained of under £10,000. Further longer-term follow-up of weight amongst study participants or additional modelling of impacts using our trial data would be required to test this hypothesis further.
Over 70% of Scottish women aged 50 to 74 years have excess body weight and 38% fail to meet physical activity recommendations  and are likely to benefit from lifestyle programmes that improve caloric intake and physical activity. In the current study, recruitment at BMI > 25 kg/m2 is important because many women will gain weight at this life stage, which is a risk factor for breast cancer (independent of actual BMI). Additionally, lifestyle habits may be worsening during the current COVID-19 pandemic. The current work demonstrates that partnerships between existing NHS services, leisure facilities and an enhanced role for third sector volunteers offer significant potential for greater ‘reach’ of weight loss programmes. Lifestyle interventions initiated in the breast cancer screening setting are a largely unexplored area , although repeated triennial appointments offer unique opportunities for initiation and re-enforcement of current evidence on lifestyle and breast cancer risk reduction and help to avoid a “certificate of health” effect . In 2007, Fisher et al.  reported that most women attending breast screening clinics were interested in receiving lifestyle advice, and an updated paper  reporting the views of 1803 women shows overwhelming support for receiving interventions.. Sinclair et al.  have also demonstrated that the breast clinic setting is an acceptable opportunity to discuss alcohol use. Using data obtained from a cross sectional population representative survey on early detection and prevention, Stevens et al. [50, 51] reported that across breast, cervical and colorectal screening programmes respondents report acceptability of and considerable willingness [51, 52] to receive healthy lifestyle advice and particularly weight management guidance in women with excess body weight. Health behaviour interventions offered within colorectal cancer screening programmes have also been shown to provide an effective route for change in lifestyle [41, 53].
However, future research is needed to identify how to achieve wider engagement with women living in more deprived circumstances and the challenge of achieving large weight loss and weight loss maintenance.
A community weight management intervention initiated at breast screening clinics and delivered by volunteer coaches highlights significant opportunities for the use of a community assets approach to attain significant weight loss over a 12 month period and support breast cancer risk reduction in older women.
Availability of data and materials
The authors are prepared to share anonymised participant data following reasonable request for same.
The Scottish Public Health Observatory (Cited 2020 July 1). https://www.scotpho.org.uk/health-wellbeing-and-disease/cancer-breast/data/scottish/.
Information Service Division (Internet). Cancer Incidence Projections for Scotland 2013-2027 (Cited 2020 July 1). http://www.isdscotland.org/Health-Topics/Cancer/Publications/2015-08-18/2015-08-18-Cancer-Incidence-Projections-Report.pdf.
Howell A, Anderson AS, Clarke RB, Duffy SW, Evans G, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014;16:446.
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.
Cancer Research UK (Internet). (Cited 2020 July 1). https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/deprivation-gradient#heading-One.
Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomark Prev. 2005;14(3):656–61.
Luo J, Hendryx M, Manson JE, Figueiredo JC, LeBlanc ES, Barrington W, et al. Intentional Weight Loss and Obesity-Related Cancer Risk. JNCI Cancer Spectr. 2019;3(4):pkz054. https://doi.org/10.1093/jncics/pkz054.
Teras LR, Patel AV, Wang M, Yuan SS, Anderson KBraithwaite R, et al. Sustained weight loss and risk of breast cancer in women ≥50 years: a pooled analysis of prospective data. J Natl Cancer Inst. 2019. https://doi.org/10.1093/jnci/djz226.
National Institute for Health and Care Excellence (Internet). Weight management: lifestyle services for overweight or obese adults. Public health guideline (PH53) (Cited July 1 2020). www.nice.org.uk/guidance/ph53.
Hastert TA, Beresford SAA, Patterson RE, Alan R. Kristal AR, White E. Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2013;22:1498–508.
Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to diet and physical activity Cancer prevention guidelines and Cancer outcomes: a systematic review. Cancer Epidemiol Biomark Prev. 2016;25(7):1018–28.
Cancer Research UK (Internet). Action on Obesity (Cited July 1 2020). https://www.cancerresearchuk.org/action-on-obesity.
Anderson AS. Improving diet and nutrition, physical activity and body weight - evidence to practice in world Cancer report – WHO Cancer Research for Cancer prevention. International Agency for Research on Cancer, 2019. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020. Accessed 28 Jan 2021.
Information Service Division (Internet). Scottish Breast Screening Programme Statistics 2015/16 (Cited July 1 2020). https://www.isdscotland.org/Health-Topics/Cancer/Publications/2019-10-08/2019-10-08-Breast-Screening-Summary.pdf?33234804869.
Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013;15(5):R92.
Anderson AS, Craigie AM, Gallant S, McAdam C, Macaskill EJ, Mutrie N, et al. Randomised controlled trial to assess the impact of a lifestyle intervention (ActWELL) in women invited to NHS breast screening. BMJ Open. 2018;8(11):1–11.
Anderson AS, Macleod M, Mutrie N, Sugden J, Dobson H, Treweek S, et al. Breast cancer risk reduction - is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme? Int J Behav Nutr Phys Act. 2014;11:156.
Baker G, Gray SR, Wright A, Fitzsimons NM, Lowry R, et al. Scottish Physical Activity Research Collaboration (SPARColl). The effect of a pedometer-based community walking intervention “Walking for Well Being in the West” on physical activity levels and health outcomes: a 12 week randomised controlled trial. Int J Behav Nutr Phys Act. 2010;7:51.
Physical Activity and Health Alliance. Scottish physical activity screening question (Scot-PASQ). 2013. Available at http://www.paha.org.uk/Resource/scottish-physical-activity-screening-question-scotpasq. Accessed 30 Mar 2018.
Scottish Government, 2017. Scottish health survey: main report [online] http://www.gov.scot/Publications/2017/10/2970/downloads. Accessed 15 Jan 2018.
Cappuccio FP, Rink E, Perkins-Porras L, et al. Estimation of fruit and vegetable intake using a two-item dietary questionnaire: a potential tool for primary health care workers. Nutr Metab Cardiovasc Dis. 2003;13:12–9. Audit C
Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789–95.
Broadbent E, Petrie KJ, Main J, et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–7.
EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
Scottish Government (Internet). Scottish index of multiple deprivation (Cited March 30 2020). http://www.scotland.gov.uk/Topics/Statistics/SIMD/.
Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005;37:S531–43.
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. https://doi.org/10.1186/1748-5908-6-42.
Scottish Intercollegiate Guidelines Network (SIGN). Management of obesity – a national clinical guidelines 115. Edinburgh: Royal College of Physicians Edinburgh; 2010.
Anderson AS, Craigie AM, Gallant S, McAdam C, Macaskill EJ, McKell J et al. Optimisation of the ActWELL lifestyle intervention programme for women attending routine NHS breast screening clinics. 2020 Trials (in press).
Breast Cancer Now. Breast cancer risk: the Facts. 5th ed; 2015.
Curtis, L, Burns A. Personal Social Services Research Unit. Unit Costs of Health and Social Care 2018. Report number: 10.22024/UniKent/01.02.70995. University of Kent, 201 pp. ISBN 978–1–911353-06-5. doi:10.22024/UniKent/01.02.70995
Department of Health (Internet). National Schedule of Reference Costs: 2017-18. 2018 (Cited July 1 2020). Available from http://eprints.whiterose.ac.uk/68857/.
International Physical Activity Questionnaire (Internet). (Cited July 1 2020). https://www.academia.edu/5346814/Guidelines_for_Data_Processing_and_Analysis_of_the_International_Physical_Activity_Questionnaire_IPAQ_Short_and_Long_Forms_Contents. Accessed 28 Jan 2021.
Aveyard P, Lewis A, Tearne S, Hood K, Christian-Brown A, Adab P, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet. 2016;388:10059;2492–2500. https://doi.org/10.1016/S0140-6736(16)31893-1.
Kraschnewski JL, Hwang KO, George DR, Lehman EB, Sciamanna CN. Feasibility of utilising an all-volunteer workforce as a disruptive innovation for the US obesity epidemic. Obes Res Clin Pract. 2014;8(5):e488–96.
Allicock M, Haynes-Maslow L, Carr C, Orr M, Kahwati LC, Weiner BJ, et al. Training veterans to provide peer support in a weight-management program: MOVE! Prev Chronic Dis. 2013;10:E185. https://doi.org/10.5888/pcd10.130084.
Bennett D, Owen T, Bradley DT. The £ for lb. challenge. Evaluation of a novel, workplace-based peer-led weight management programme, 2014-2016. Public Health. 2017;150:93–100. https://doi.org/10.1016/j.puhe.2017.05.007 Epub 2017 Jun 26.
Stead M, Eadie D, Caswell S, Craigie A, Anderson AS, the BeWEL team. Understanding the potential and challenges of adenoma treatment as a prevention opportunity: insights from the BeWEL formative study. Prev Med. 2012;54(1):97–103.
Darcey E, Ambati R, Lund H, Redfern A, Saunders C, Thompson S, et al. Measuring height and weight as part of routine mammographic screening for breast cancer. J Med Screen. 2019;26(4):204–11. https://doi.org/10.1177/0969141319860873 Epub 2019 Jul 9.
Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Coker K, Giles-Corti B, et al. How many steps/day are enough? For adults. Int J Behav Nutr Phys Act. 2011;8:79. https://doi.org/10.1186/1479-5868-8-79.
Anderson AS, Craigie AM, Caswell S, Treweek S, Stead M, Macleod M, et al. The impact of a body weight and physical activity weight loss intervention (BeWEL) initiated through a national colorectal cancer screening programme. BMJ. 2014;348:g1823.
Hunt K, Wyke S, Gray CM, Anderson AS, Brady A, Bunn C, et al. Football fans in training (FFIT): a pragmatic randomized controlled trial and cost effectiveness analysis of a gender-sensitised weight loss and healthy living programme delivered to overweight and obese men aged 35-65 by Scottish premier league (SPL) football clubs. Lancet. 2014;383(9924):1211–21.
Wyke S, Bunn C, Andersen E, Slva MN, van Nassau F, McSkimmin P, et al. The effect of a programme to improve men’s sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial. Plos Med. 2019;16(3):e1002772 doi: 101371/journalpmed1002772 eCollection 2019 Mar.
Brown M, Marsh T, Retat L, Fordham R, Suhrcke M, Turner D et al. Managing overweight and obesity among adults. Report on Economic Modelling and Cost Consequence Analysis. National Institute for Health and Care Excellence, 2013. https://www.nice.org.uk/guidance/ph53/evidence/economic-modelling-report-431715709. Accessed 28 Jan 2021.
Scottish Government. Scottish Health Survey 2018: Main report revised 2020 (Cited July 1 2020). https://www.gov.scot/publications/scottish-health-survey-2018-volume-1-main-report/.
Anderson AS, Mackison D, Boath C, Steele RJC. Promoting changes in diet and physical activity in breast and colorectal cancer screening settings- an unexplored opportunity for endorsing healthy behaviours. Cancer Prev Res (Phila). 2013;6(3):165–72.
Larsen IK, Grotmol T, Almendingen K, Hoff G. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol. 2007;5(4):477–83 Epub 2007 Mar 23.
Fisher B, Dowding D, Pickett KE, Fylan F. Health promotion at NHS breast cancer screening clinics in the UK. Health Promot Int. 2007;22(2):137–45 Epub 2007 Jan 11.
Fisher BA, Wilkinson L, Valencia A. Women's interest in a personal breast cancer risk assessment and lifestyle advice at NHS mammography screening. J Public Health (Oxf). 2017;39(1):113–21. https://doi.org/10.1093/pubmed/fdv211.
Sinclair JMA, Dutey-Magni PF, Anderson AS, Baird J, Barker ME, Cutress RI, et al. A Context-Specific Digital Alcohol Brief Intervention in Symptomatic Breast Clinics (Abreast of Health): Development and Usability Study. JMIR Res Protoc. 2020;9(1):e14580. https://doi.org/10.2196/14580https://www.ncbi.nlm.nih.gov/pubmed/32012091.
Stevens C, Vrinten C, Smith SG, Waller J, Beeken RJ. Determinants of willingness to receive healthy lifestyle advice in the context of cancer screening. Br J Cancer. 2018;119(2):251–7. https://doi.org/10.1038/s41416-018-0160-4 Epub 2018 Jul 11.
Stevens C, Vrinten C, Smith SG, Waller J, Beeken RJ. Acceptability of receiving lifestyle advice at cervical, breast and bowel cancer screening. Prev Med. 2019;120:19–25. https://doi.org/10.1016/j.ypmed.2018.12.005 Epub 2018 Dec 19.
Knudsen MD, Hjartåker A, Robb KA, de Lange T, Hoff G, Berstad P. Improving Cancer Preventive Behaviors: A Randomized Trial of Tailored Lifestyle Feedback in Colorectal Cancer Screening. Cancer Epidemiol Biomark Prev. 2018;27(12):1442–9. https://doi.org/10.1158/1055-9965.EPI-18-0268 Epub 2018 Nov 2.
Our thanks to Elizabeth Banks who advised and assisted with many aspects of the study and also to the many women who commented on the development and design of this study including those on our Public Advisory Team (Pamela Deponio, Maggie Taylor and Mary Wotherspoon).
This work was supported by The Scottish Government, grant number BC/Screening/17/01. The funders provided independent referee reports which guided the final study design. The funders have read this manuscript. In-kind support was given by Breast Cancer Now for facilitating this study.
Ethics approval and consent to participate
The protocol has been approved by East of Scotland Research Ethics Committee (17/ES/0073). All participants provided written informed consent before participation.
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
About this article
Cite this article
Anderson, A.S., Chong, H.Y., Craigie, A.M. et al. A novel approach to increasing community capacity for weight management a volunteer-delivered programme (ActWELL) initiated within breast screening clinics: a randomised controlled trial. Int J Behav Nutr Phys Act 18, 34 (2021). https://doi.org/10.1186/s12966-021-01099-7
- Breast cancer body weight lifestyle
- Intervention screening
- Physical activity
- Cost-effectiveness analysis